semaglutide prefilled syringe Fitaro pre-filled (various dosage strengths) and reduced Semalix 0.25 mg/0.5 mg Pre-filled

In the SUSTAIN 6 trial, over 3,297 patients with type 2 diabetes with established chronic kidney disease and/or cardiovascular disease underwent randomization to semaglutide or placebo and were followed for 2 years resulting in a 26% risk reduction in the combined endpoint of rate of cardiovascular disease, nonfatal myocardial infarction, or nonfatal stroke [47]

Chen YC, Jandeleit-Dahm K, Peter K

Manufactured through controlled production workflows, each lot is handled under internal quality procedures designed to support consistency, documentation, and traceability

Sensitivity analyses for WL outcome also remained non-significant when each study was omitted individually (Supplementary Fig